18F-Fluorocholine PET and Multiphase CT Integrated in Dual Modality PET/4D-CT for Preoperative Evaluation of Primary Hyperparathyroidism

被引:32
作者
Pretet, Valentin [1 ]
Rotania, Marianela [1 ,2 ]
Helali, Mehdi [1 ]
Ignat, Mihaela [3 ]
Vix, Michel [3 ]
Imperiale, Alessio [1 ,4 ,5 ]
机构
[1] ICANS Univ Hosp Strasbourg, Nucl Med & Mol Imaging, F-67033 Strasbourg, France
[2] Inst Oulton, Mol & Nucl Med, X5000 JJS, Cordoba, Argentina
[3] Univ Strasbourg, IRCAD IHU, Gen Digest & Endocrine Surg, F-67033 Strasbourg, France
[4] Univ Strasbourg, Fac Med, F-67033 Strasbourg, France
[5] CNRS Unistra, IPHC, Mol Imaging DRHIM, UMR 7178, F-67033 Strasbourg, France
关键词
F-18-Fluorocholine PET; 4D contrast-enhanced CT; primary hyperparathyroidism; parathyroid; adenoma; ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; COMPUTED-TOMOGRAPHY; LOCALIZATION; SCINTIGRAPHY; MANAGEMENT; SPECT/CT; SURGERY; UPDATE;
D O I
10.3390/jcm9062005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present retrospective study evaluates the diagnostic value of integrated(18)F-Fluorocholine positron emission tomography/four-dimensional contrast-enhanced computed tomography (F-18-FCH PET/4D-CT) as second-line imaging in preoperative work-up of primary hyperparathyroidism (pHPT), and compares(18)F-FCH PET with 4D-CT. Patients with pHPT and negative/discordant first-line imaging addressed for integrated(18)F-FCH PET/4D-CT were retrospectively selected. Sensitivity and detection rate (DR%) of(18)F-FCH PET/CT, 4D-CT, and PET/4D-CT were calculated according to the per patient and per lesion analyses, and afterwards compared. Histology associated with a decrease more than 50% of perioperative parathyroid hormone (PTH) blood level was used as a gold standard. Persistent high serum PTH and calcium levels during a 6-month follow-up was considered as presence of pHPT in both operated and non-operated patients. 50 patients (55 glands) were included. 44/50 patients (88%) were surgically treated. On a per patient analysis, sensitivity was 93%, 80%, and 95%, and DR% was 82%, 68%, and 84%, respectively for PET/CT, 4D-CT, and PET/4D-CT. PET/CT was more sensitive than 4D-CT (p= 0.046). PET/4D-CT performed better than 4D-CT (p= 0.013) but was equivalent to PET/CT alone. On a per gland analysis, sensitivity PET/CT, 4D-CT, and PET/4D-CT was 88%, 66%, and 92%, and DR% was 79%, 57%, and 83%, respectively. PET/CT and PET/4D-CT were more sensitive than 4D-CT alone (p= 0.01,p< 0.001, respectively). However, PET/CT and PET/4D-CT performed similarly. In conclusion,F-18-FCH PET provides better identification of hyperfunctioning parathyroids than 4D-CT and the combination of both did not significantly improve diagnostic sensitivity. Further investigations involving larger populations are necessary to define the role of(18)F-FCH PET/4D-CT as a "one-stop shop" second-line imaging in preoperative work-up of pHPT, especially considering the additional patient radiation exposure due to multi-phase CT.
引用
收藏
页数:12
相关论文
共 34 条
[21]   Medical progress - Hyperparathyroid and hypoparathyroid disorders [J].
Marx, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) :1863-1875
[22]   Multiphase computed tomography for localization of parathyroid disease in patients with primary hyperparathyroidism: How many phases do we really need? [J].
Noureldine, Salem I. ;
Aygun, Nafi ;
Walden, Michael J. ;
Hassoon, Ahmed ;
Gujar, Sachin K. ;
Tufano, Ralph P. .
SURGERY, 2014, 156 (06) :1300-1307
[23]   The diagnostic value of 4D MRI at 3T for the localization of parathyroid adenomas [J].
Ozturk, Mesut ;
Polat, Ahmet Veysel ;
Celenk, Cetin ;
Elmali, Muzaffer ;
Kir, Seher ;
Polat, Cafer .
EUROPEAN JOURNAL OF RADIOLOGY, 2019, 112 :207-213
[24]   Additional value of integrated 18F-choline PET/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile [J].
Piccardo, Arnoldo ;
Trimboli, P. ;
Rutigliani, M. ;
Puntoni, M. ;
Foppiani, L. ;
Bacigalupo, L. ;
Crescenzi, Anna ;
Bottoni, G. ;
Treglia, G. ;
Paparo, F. ;
Del Monte, P. ;
Lanata, M. ;
Paone, G. ;
Ferrarazzo, G. ;
Catrambone, U. ;
Arlandini, A. ;
Ceriani, L. ;
Cabria, M. ;
Giovanella, L. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) :766-775
[25]   A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003 [J].
Ruda, JM ;
Hollenbeak, CS ;
Stack, BC .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2005, 132 (03) :359-372
[26]   Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis [J].
Sejean, K ;
Calmus, S ;
Durand-Zaleski, I ;
Bonnichon, P ;
Thomopoulos, P ;
Cormier, C ;
Legmann, P ;
Richard, B ;
Bertagna, XY ;
Vidal-Trecan, GM .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 153 (06) :915-927
[27]   Comparison of 4D CT, Ultrasonography, and 99mTc Sestamibi SPECT/CT in Localizing Single-Gland Primary Hyperparathyroidism [J].
Suh, Yong Joon ;
Choi, June Young ;
Kim, Su-jin ;
Chun, In Kook ;
Yun, Tae Jin ;
Lee, Kyu Eun ;
Kim, Ji-hoon ;
Cheon, Gi Jeong ;
Youn, Yeo-Kyu .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (03) :438-443
[28]  
Taywade Sameer K, 2017, Indian J Endocrinol Metab, V21, P399, DOI 10.4103/ijem.IJEM_536_16
[29]   Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis [J].
Treglia, Giorgio ;
Piccardo, Arnoldo ;
Imperiale, Alessio ;
Strobel, Klaus ;
Kaufmann, Philipp A. ;
Prior, John O. ;
Giovanella, Luca .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) :751-765
[30]   Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods [J].
Treglia, Giorgio ;
Trimboli, Pierpaolo ;
Huellner, Martin ;
Giovanella, Luca .
MINERVA ENDOCRINOLOGICA, 2018, 43 (02) :133-143